Skip to main content
68th Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Red Recording
Sig Meeting
Sig Meeting

Therapeutics (Industry)

(T 33) Symbravo® (MoSEIC(TM) meloxicam and rizatriptan) for the Acute Treatment of Migraine: Post-hoc Composite Efficacy and Safety Endpoint Analysis of INTERCEPT and MOMENTUM

    Presenting Author(s)

  • Fred Cohen, n/a

    Assistant Professor
    Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    New York, NY, United States

    • Non-presenting Author(s)

  • GE

    Graham M.L. Eglit, PhD

    Axsome Therapeutics, Inc.
    New York, New York, United States

  • CL

    Cherisse Loucks, PhD

    Director
    Axsome Therapeutics, Inc.
    New York, NY, United States

  • AC

    Angad Chhabra, BS

    Axsome Therapeutics, Inc.
    New York, New York, United States

  • TG

    Todd Grinnell, BS

    Axsome Therapeutics, Inc.
    New York, New York, United States

  • ST

    Stewart J. Tepper, MD

    Geisel Professor of Neurology; Vice President, NEINH
    The New England Institute for Neurology and Headache, Stamford, CT, USA
    Pound Ridge, NY, United States